Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

BACKGROUND: In stage III non-small cell lung cancer (NSCLC) treated with concomitant chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local and can be treated by stereotactic ablative radiation therapy (SABR). Previous studies reporting outcome after SABR reirradia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Sumodhee, Shakeel, Bondiau, Pierre-Yves, Poudenx, Michel, Cohen, Charlotte, Naghavi, Arash O., Padovani, Bernard, Maneval, Daniel, Gal, Jocelyn, Leysalle, Axel, Ghalloussi, Hannah, Otto, Josiane, Doyen, Jérôme
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6448259/
https://ncbi.nlm.nih.gov/pubmed/30943943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5542-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados